Access to Antiretroviral Therapy in Uganda: Kampala, June 2002
This research is an attempt to understand the current situation in Uganda int erms of access to ARVs. It describes what role generic alternatives to branded ARVs have played in reducing prices and increasing access to antiretroviral therapies (ART). In addition, it reviews the laws governing pharmaceutical patients in Uganda, as well as the newly proposed Industrial Property Bill 2002 (IP Bill). Finally, the thoughts and comments of some HIV-infected patients regarding affordability of medications are also included.